West Nile Virus
Several infectious agents have emerged over the past two decades as a result of population migration and enhanced world travel. The introduction of arthropodborne infections to formerly unaffected geographic areas has occurred in the western hemisphere at an alarming rate. In 1999, the West Nile virus (WNV) first appeared in North America in Queens, New York and spread rapidly to infect bird and mosquito populations along the Atlantic and Gulf coasts. Significant human morbidity and mortality has been associated with the virus, with several patients deaths from encephalitis. Specific antiviral therapy is currently unavailable, but recommendations for a national plan to control and prevent the spread of this vector-borne disease have been made by the Centers for Disease Control and Prevention. Educating the public about how WNV is transmitted, how to best protect one's self, and what signs and symptoms are consistent with this infection are extremely important. Pharmacists, who have more patient interactions per unit time than any other health care provider group, are in an excellent position to play a pivotal role in this educational effort.